UV disinfection reduces multidrug-resistant organisms at NY hospital

The rates during UV environmental disinfection are the lowest incidence rates for the past 10 years and were sustained for 22 months


Hospital-acquired multidrug-resistant (MDR) organisms and Clostridium difficile significantly decreased after adding ultraviolet environmental disinfection to the standard cleaning regimen in high-risk areas at the Westchester Medical Center in New York, according to an article on the Healio website.

The decrease in MDR organisms was led by a significant decrease in vancomycin-resistant enterococci (VRE), which was the hospital’s most common MDR organism, according to the report in the American Journal of Infection Control.

“Although there were many other simultaneous infection control interventions occurring at our hospital that could have contributed to the reduction in VRE acquisition, the rates experienced during UV environmental disinfection are the lowest incidence rates of VRE at our institution for the past 10 years and were sustained for 22 months,” the researchers said.

Read the article.

 

 



July 2, 2014


Topic Area: Safety


Recent Posts

Disinfectant Contact Time: The Case for Biofilm Disruption

Contact time, while essential for compliance, does not reliably predict microbial reduction on actual healthcare surfaces.


Texas HHSC Reaches Construction Milestone for Panhandle State Hospital in Amarillo

Construction is expected to be completed in fall 2027.


Mon General Succumbs to Phishing Cyberattack

Its investigation ultimately determined that an unauthorized party gained access to certain Mon General email mailboxes on May 6, 2026.


The HVAC Dilemma: To Repair or Replace?

Healthcare facilities that keep repairing and optimizing aging systems past their useful life spend money on a problem they cannot solve without capital investment.


Department of Veterans Affairs Signs Lease for Community-Based Outpatient Clinic in Kentucky

Construction and facility preparation are expected to be completed by the winter of 2027, and the first patient should be seen by spring 2028.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.